• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

University of Leicester researcher awarded £2m to tackle childhood sight loss

Aug 13, 2026

University researcher, Dr Mervyn Thomas, has been awarded just over £2 million to understand why some children’s eyes do not develop as they should.

Dr Mervyn Thomas

The Career Development Award, from the Wellcome Trust, provides funding to conduct relevant research into the Fovea – the tiny region of the eye no bigger than a pinhead which we rely on to give us sharp and detailed vision.

Damage to the fovea significantly reduces visual sharpness, making even simple visual tasks challenging. In some children the fovea fails to develop properly, a condition called foveal hypoplasia, leaving them partially sighted or registered blind.

This award funds eight years of research to understand how the fovea normally develops, why it sometimes goes wrong, and what that means for the children affected. The human fovea reaches maturity during childhood and can also deteriorate as we get older.

Speaking about the award, Dr Thomas, Clinical Associate Professor, Honorary Consultant Ophthalmologist and Clinical Lead at the Ulverscroft Eye Unit at the University of Leicester, said: “I hope that by the end of this programme, when a family sits in front of me and asks why this happened to their child, I will finally have an answer.

“My aim is to understand whether there is a window early in a child’s development where we could intervene, and if so, which biological pathways we would need to target. Those are questions we cannot even begin to answer right now but I hope this research will put us in a position to ask them properly for the first time.”

Funding will pay for a dedicated research programme in Leicester, focussed on normal and abnormal foveal development. The programme will create novel models that mimic human foveal disorders, testing whether restoring faulty biological pathways can rescue normal development, and imaging patients using a custom-built ultra-high-resolution eye scanner to study the fovea at a level of detail never before possible in a clinic.

Dr Thomas added: “I have been fascinated by the fovea from my time at medical school. It has amazed me how this structure develops and contributes to our vision.

Now as a clinician, I sit with children and families affected by foveal hypoplasia and face questions I cannot yet answer including: Why did this happen? Will there ever be anything we can do?

“This award gives my team the opportunity to begin answering those questions. Right now we simply do not understand enough about how the fovea develops to know whether we can or where to intervene. But this research could change that, and in doing so, open the door to possibilities that don’t yet exist for these families.

“It is also a recognition of everyone who has contributed to this work, my team, collaborators, and most importantly the patients who trust us with their care.”

Professor Tom Robinson, Head of the College of Life Sciences at the University of Leicester, said: “Congratulations to Dr Thomas for this hugely prestigious Career Development Award. It truly is recognition of the high quality and pioneering nature of research taking place which will have a real-world impact. Dr Thomas and his team reflect all that we seek here at Leicester – to be true Citizens of Change.”

The London-based Wellcome Trust is one of the world’s largest independent charitable foundations and supports science to solve urgent health challenges.

Category: Press Releases

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}